Search research articles
Contact Us
Filters
Showing results (21-30 of 67) with videos related to
Page
of 7
Sort By:
Journal of the Neurological Sciences
|
July 18, 2016
A cross-sectional structured survey of patients receiving botulinum toxin type A treatment for blepharospasm
John Fezza, John Burns, Julie Woodward, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences
|
September 21, 2011
Determination of the Boltzmann constant using a quasi-spherical acoustic resonator
Laurent Pitre, Fernando Sparasci, Daniel Truong, et al.
The Review of Scientific Instruments
|
August 1, 2016
High resolution kilometric range optical telemetry in air by radio frequency phase measurement
Joffray Guillory, Radek Šmíd, Jorge García-Márquez, et al.
Journal of the Neurological Sciences
|
September 5, 2014
IncobotulinumtoxinA (Xeomin®) injected for blepharospasm or cervical dystonia according to patient needs is well tolerated
Virgilio Gerald H Evidente, Daniel Truong, Joseph Jankovic, et al.
Toxicon : Official Journal of the International Society on Toxinology
|
November 27, 2012
Evidence-based review and assessment of botulinum neurotoxin for the treatment of secretory disorders
Markus Naumann, Dirk Dressler, Mark Hallett, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
August 11, 2012
AbobotulinumtoxinA (Dysport) dosing in cervical dystonia: an exploratory analysis of two large open-label extension studies
Robert A Hauser, Daniel Truong, Jean Hubble, et al.
Parkinsonism & Related Disorders
|
April 3, 2010
Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia
Daniel Truong, Matthew Brodsky, Mark Lew, et al.
Toxicon : Official Journal of the International Society on Toxinology
|
February 6, 2013
Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders
Mark Hallett, Alberto Albanese, Dirk Dressler, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation
|
September 28, 2016
Poster 296 AbobotulinumtoxinA Injection Patterns in Patients with Cervical Dystonia from the ANCHOR-CD Registry Study
Cynthia L Comella, George C Camba, Daniel Truong, et al.
Frontiers in Neurology
|
September 28, 2020
Prodromal Markers of Parkinson's Disease in Patients With Essential Tremor
Xi-Xi Wang, Ya Feng, Xuan Li, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 67) with videos related to
Sort By:
Page
of 7
Journal of the Neurological Sciences
|
July 18, 2016
A cross-sectional structured survey of patients receiving botulinum toxin type A treatment for blepharospasm
John Fezza, John Burns, Julie Woodward, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences
|
September 21, 2011
Determination of the Boltzmann constant using a quasi-spherical acoustic resonator
Laurent Pitre, Fernando Sparasci, Daniel Truong, et al.
The Review of Scientific Instruments
|
August 1, 2016
High resolution kilometric range optical telemetry in air by radio frequency phase measurement
Joffray Guillory, Radek Šmíd, Jorge García-Márquez, et al.
Journal of the Neurological Sciences
|
September 5, 2014
IncobotulinumtoxinA (Xeomin®) injected for blepharospasm or cervical dystonia according to patient needs is well tolerated
Virgilio Gerald H Evidente, Daniel Truong, Joseph Jankovic, et al.
Toxicon : Official Journal of the International Society on Toxinology
|
November 27, 2012
Evidence-based review and assessment of botulinum neurotoxin for the treatment of secretory disorders
Markus Naumann, Dirk Dressler, Mark Hallett, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
August 11, 2012
AbobotulinumtoxinA (Dysport) dosing in cervical dystonia: an exploratory analysis of two large open-label extension studies
Robert A Hauser, Daniel Truong, Jean Hubble, et al.
Parkinsonism & Related Disorders
|
April 3, 2010
Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia
Daniel Truong, Matthew Brodsky, Mark Lew, et al.
Toxicon : Official Journal of the International Society on Toxinology
|
February 6, 2013
Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders
Mark Hallett, Alberto Albanese, Dirk Dressler, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation
|
September 28, 2016
Poster 296 AbobotulinumtoxinA Injection Patterns in Patients with Cervical Dystonia from the ANCHOR-CD Registry Study
Cynthia L Comella, George C Camba, Daniel Truong, et al.
Frontiers in Neurology
|
September 28, 2020
Prodromal Markers of Parkinson's Disease in Patients With Essential Tremor
Xi-Xi Wang, Ya Feng, Xuan Li, et al.
Page
of 7